Company registration number 04159176 (England and Wales)
KRESCENDO LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
KRESCENDO LIMITED
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 9
KRESCENDO LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
5
1,991
2,767
Current assets
Debtors
6
674,068
713,127
Cash at bank and in hand
1,426,034
1,479,190
2,100,102
2,192,317
Creditors: amounts falling due within one year
7
(176,289)
(161,039)
Net current assets
1,923,813
2,031,278
Total assets less current liabilities
1,925,804
2,034,045
Provisions for liabilities
(302)
Net assets
1,925,804
2,033,743
Capital and reserves
Called up share capital
9
70
70
Share premium account
49,975
49,975
Capital redemption reserve
41
41
Profit and loss reserves
1,875,718
1,983,657
Total equity
1,925,804
2,033,743
The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true
For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved and signed by the director and authorised for issue on 12 September 2025
Mr G Albarosa
Director
Company Registration No. 04159176
KRESCENDO LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
Share capital
Share premium account
Capital redemption reserve
Profit and loss reserves
Total
Notes
£
£
£
£
£
Balance at 1 January 2023
70
49,975
41
1,934,942
1,985,028
Year ended 31 December 2023:
Profit and total comprehensive income for the year
-
-
-
94,965
94,965
Dividends
-
-
-
(100,000)
(100,000)
Credit to equity for equity settled share-based payments
10
-
-
-
53,750
53,750
Balance at 31 December 2023
70
49,975
41
1,983,657
2,033,743
Year ended 31 December 2024:
Profit and total comprehensive income for the year
-
-
-
180,811
180,811
Dividends
-
-
-
(340,000)
(340,000)
Credit to equity for equity settled share-based payments
10
-
-
-
51,250
51,250
Balance at 31 December 2024
70
49,975
41
1,875,718
1,925,804
KRESCENDO LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
1
Accounting policies
Company information
Krescendo Limited is a private company limited by shares incorporated in England and Wales. The registered office is 77 Marsh Wall, London, England, E14 9SH.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention.
The company continues to trade profitably in 2025 and the director considers there to be no reason to foresee this to change in the future. The director considers there are no material uncertainties that may cast significant doubt on the ability of the company to continue as a going concern.
1.2
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT.
1.3
Intangible fixed assets - goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2007, is amortised evenly over its useful life of ten years.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and Machinery
33% Straight Line Basis
Fixtures and fittings
20% Straight Line Basis
Comp Equipment
33% Straight Line Basis
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.5
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
KRESCENDO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 4 -
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
1.6
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.7
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
KRESCENDO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 5 -
1.8
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.9
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
1.10
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.11
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.12
Share-based payments
Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted. The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest. A corresponding adjustment is made to equity.
When the terms and conditions of equity-settled share-based payments at the time they were granted are subsequently modified, the fair value of the share-based payment under the original terms and conditions and under the modified terms and conditions are both determined at the date of the modification. Any excess of the modified fair value over the original fair value is recognised over the remaining vesting period in addition to the grant date fair value of the original share-based payment. The share-based payment expense is not adjusted if the modified fair value is less than the original fair value.
Cancellations or settlements (including those resulting from employee redundancies) are treated as an acceleration of vesting and the amount that would have been recognised over the remaining vesting period is recognised immediately.
KRESCENDO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 6 -
1.13
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
3
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2024
2023
Number
Number
Total
18
20
4
Intangible fixed assets
Goodwill
£
Cost
At 1 January 2024 and 31 December 2024
122,000
Amortisation and impairment
At 1 January 2024 and 31 December 2024
122,000
Carrying amount
At 31 December 2024
At 31 December 2023
KRESCENDO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
5
Tangible fixed assets
Plant and Machinery
Fixtures and fittings
Comp Equipment
Total
£
£
£
£
Cost
At 1 January 2024
2,027
4,743
115,780
122,550
Additions
1,502
1,502
At 31 December 2024
2,027
4,743
117,282
124,052
Depreciation and impairment
At 1 January 2024
2,027
4,743
113,013
119,783
Depreciation charged in the year
2,278
2,278
At 31 December 2024
2,027
4,743
115,291
122,061
Carrying amount
At 31 December 2024
1,991
1,991
At 31 December 2023
2,767
2,767
6
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
623,022
661,433
Other debtors
478
216
Prepayments and accrued income
50,437
51,478
673,937
713,127
2024
2023
Amounts falling due after more than one year:
£
£
Deferred tax asset (note 8)
131
Total debtors
674,068
713,127
KRESCENDO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
7
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
41,558
41,820
Corporation tax
78,376
50,519
Other taxation and social security
41,359
38,446
Other creditors
14,996
30,254
176,289
161,039
8
Deferred taxation
The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:
Liabilities
Liabilities
Assets
Assets
2024
2023
2024
2023
Balances:
£
£
£
£
Accelerated capital allowances
-
302
131
-
2024
Movements in the year:
£
Liability at 1 January 2024
302
Credit to profit or loss
(433)
Asset at 31 December 2024
(131)
9
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A shares of 0.1p each
35,070
35,070
36
36
Ordinary B shares of 0.1p each
17,465
17,465
17
17
Ordinary C shares of 0.1p each
17,465
17,465
17
17
70,000
70,000
70
70
On 7 February 2023 3,465 'A' ordinary shares were redesignated as 3,465 'B' ordinary shares and a further 3,465 'A' ordinary shares were redesignated as 'C' ordinary shares.
10
Share-based payment transactions
During the previous year share options have been granted to seven employees of the company under the EMI approved employee share scheme.
KRESCENDO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
10
Share-based payment transactions
(Continued)
- 9 -
Number of share options
Weighted average exercise price
2024
2023
2024
2023
Number
Number
£
£
Outstanding at 1 January 2024
15,050
15,050
25.00
25.00
Forfeited
25.00
Outstanding at 31 December 2024
14,350
15,050
25.00
25.00
Exercisable at 31 December 2024
During 2021 the company issued 16,450 EMI share options at an exercise price of £25. During 2022 1,400 EMI share options were forfeited due to an employee leaving the company's employment. During the year a further 700 EMI share options were forfeited due to another employee leaving the company's employment, and the remainder of these options remained in issue at 31 December 2024. The options are exercisable only in the event of a company sale or similar event. A share based payment charge of £51,250 (2023: £53,750) was made for the year.
11
Parent company
There is no controlling shareholder.
2024-12-312024-01-01falsefalsefalse12 September 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityMr G Albarosa041591762024-01-012024-12-31041591762024-12-31041591762023-12-3104159176core:PlantMachinery2024-12-3104159176core:FurnitureFittings2024-12-3104159176core:ComputerEquipment2024-12-3104159176core:PlantMachinery2023-12-3104159176core:FurnitureFittings2023-12-3104159176core:ComputerEquipment2023-12-3104159176core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3104159176core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3104159176core:CurrentFinancialInstruments2024-12-3104159176core:CurrentFinancialInstruments2023-12-3104159176core:ShareCapital2024-12-3104159176core:ShareCapital2023-12-3104159176core:SharePremium2024-12-3104159176core:SharePremium2023-12-3104159176core:CapitalRedemptionReserve2024-12-3104159176core:CapitalRedemptionReserve2023-12-3104159176core:RetainedEarningsAccumulatedLosses2024-12-3104159176core:RetainedEarningsAccumulatedLosses2023-12-3104159176core:ShareCapital2022-12-3104159176core:SharePremium2022-12-3104159176core:CapitalRedemptionReserve2022-12-3104159176core:RetainedEarningsAccumulatedLosses2022-12-31041591762022-12-3104159176core:ShareCapitalOrdinaryShareClass12024-12-3104159176core:ShareCapitalOrdinaryShareClass12023-12-3104159176core:ShareCapitalOrdinaryShareClass22024-12-3104159176core:ShareCapitalOrdinaryShareClass22023-12-3104159176core:ShareCapitalOrdinaryShareClass32024-12-3104159176core:ShareCapitalOrdinaryShareClass32023-12-3104159176core:ShareCapitalOrdinaryShares2024-12-3104159176core:ShareCapitalOrdinaryShares2023-12-3104159176bus:Director12024-01-012024-12-3104159176core:RetainedEarningsAccumulatedLosses2023-01-012023-12-31041591762023-01-012023-12-3104159176core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3104159176bus:RegisteredOffice2024-01-012024-12-3104159176core:Goodwill2024-01-012024-12-3104159176core:PlantMachinery2024-01-012024-12-3104159176core:FurnitureFittings2024-01-012024-12-3104159176core:ComputerEquipment2024-01-012024-12-3104159176core:NetGoodwill2023-12-3104159176core:NetGoodwill2024-12-3104159176core:NetGoodwill2023-12-3104159176core:PlantMachinery2023-12-3104159176core:FurnitureFittings2023-12-3104159176core:ComputerEquipment2023-12-31041591762023-12-3104159176core:Non-currentFinancialInstruments2024-12-3104159176core:Non-currentFinancialInstruments2023-12-3104159176bus:OrdinaryShareClass12024-01-012024-12-3104159176bus:OrdinaryShareClass22024-01-012024-12-3104159176bus:OrdinaryShareClass32024-01-012024-12-3104159176bus:OrdinaryShareClass12024-12-3104159176bus:OrdinaryShareClass12023-12-3104159176bus:OrdinaryShareClass22024-12-3104159176bus:OrdinaryShareClass22023-12-3104159176bus:OrdinaryShareClass32024-12-3104159176bus:OrdinaryShareClass32023-12-3104159176bus:AllOrdinaryShares2024-12-3104159176bus:AllOrdinaryShares2023-12-3104159176bus:PrivateLimitedCompanyLtd2024-01-012024-12-3104159176bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3104159176bus:SmallEntities2024-01-012024-12-3104159176bus:AuditExemptWithAccountantsReport2024-01-012024-12-3104159176bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP